Glenmark Sun Pharma Zydus Recall Over 40 Products in US Amid Safety Concerns
Indian pharmaceutical giants Glenmark, Sun Pharma, and Zydus are recalling over 40 products in the US due to manufacturing issues, as per the US Food and Drug Administration (USFDA).
Mumbai-based Glenmark initiated a Class II recall on March 13, 2025, for over 25 products, including Propafenone Hydrochloride capsules, Solifenacin Succinate tablets, and others, citing Current Good Manufacturing Practice (CGMP) deviations.
Sun Pharma’s US subsidiary recalled 13,700 bottles of Gabapentin capsules, a seizure medication, on March 4, 2025, due to cross-contamination concerns. The company classified this as a Class III recall.
Additionally, Zydus Pharmaceuticals (USA) pulled back 3,144 bottles of Chlorpromazine Hydrochloride tablets on April 3, 2025, after detecting N-Nitroso-Desmethyl Chlorpromazine impurities exceeding limits. This was categorized as a Class II recall.
USFDA explained that Class II recalls address products with temporary or reversible health risks, while Class III recalls involve minimal health consequences. These recalls highlight ongoing challenges with quality control in the global pharmaceutical supply chain.
2026-10-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Indorama Corporation Acquires 100% Stake in Anyang Zhongying Fertilizer
-
“Anti-Overcapacity” Backfires: China’s Chemical Industry Trapped in a Hell of Its Own Making—and Global Pushback
-
Saint-Gobain Expands Its Construction Chemicals Operations in Indonesia
-
China, U.S. and Australia Escalate Antidumping Scrutiny: Chemical Exports Face Rising Compliance Pressure
-
German Chemical Sentiment Hits a Three-Year Low: Supply Disruption Amplifies Pressure on European Manufacturing
-
Asia’s Plastics Chain Faces a Shock: Tight Naphtha Supply Drives Up Polymer Costs
-
EU Chemical Antidumping Complaints Hit a Record High: Trade Remedies Reshape Export Competition
-
New York’s Additive Ban Signals a Tougher Era for Food Formulation
-
Oil-Coal Price Gap Widens! Coal Chemical Enterprises See Significant Profit Surge in H1 2026
-
Domo Chemicals’ German Subsidiary Insolvencies: Energy Costs, Weak Demand and Chinese Nylon Competition
Recommend Reading
-
Invista Reshuffles Global Nylon 66 Map: Shutting US and UK Plants, Betting Big on China—What Exactly Are They Aiming For?
-
China’s PE, PP and PVC Exports Rise as Stockpile Releases Reshape Global Supply
-
Global Oil Inventories Fall: Restocking Demand May Keep Petrochemical Costs Supported
-
Wuxi Yinda Nylon Acquires German Century-Old Chemical Giant Perlon
-
India Swings the Tariff Axe at Made-in-China: Epoxy Resins Are Just the Beginning—The Road for Chinese Chemicals Abroad Is No Longer Smooth
-
Raw Materials Strong, Demand Weak—ABS Prices Rise in July and Then Stabilize
-
Business Society’s Market Outlook for Petroleum Coke on August 24, 2026: Volatile
-
China's Natural Rubber Spot Market Shows Fluctuating Uptrend
-
Business Society’s Market Outlook for Fuel Oil 180CST on August 24, 2026: Volatile
-
Raw Materials Strengthen; PC Prices Show Volatility with a Rise at Late January
- Hot Searches
- benzene and styrene prices
- samarium oxide 3n price 2025
- na-931 for sale
- boric cid
- o que é sesame oil
- semaglutide research peptide for sale
- soy protein isolate supplier
- magnesium oxide nanopowder market
- buy potassium cyanide
- ammonia nitrate prill
- fluocinolone acetonide oil
- benzene for sale